LogicBio Therapeutics, Inc. today announced that president and chief executive officer, Fred Chereau , will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on Wednesday, September 29, 2021 at 8:00 a.m. ET.
| LEXINGTON, Mass., Sept. 24, 2021 /PRNewswire/ --LogicBio Therapeutics (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood, today announced that president and chief executive officer, Fred Chereau, will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on Wednesday, September 29, 2021 at 8:00 a.m. ET. A live webcast of the fireside chat will be made available on the Investors section of the Company’s website at www.logicbio.com/investors. The webcast replay will be available for approximately 30 days. About LogicBio Therapeutics Investor Contacts: Stephen Jasper Media Contacts: Jenna Urban
SOURCE LogicBio Therapeutics, Inc. | ||
Company Codes: NASDAQ-NMS:LOGC |
View original content:
